DJIA 17,122.01 15.31 0.09%
NASDAQ 4,569.62 -1.02 -0.02%
S&P 500 2,000.12 0.10 0.00%
market minute promo

1.37 -0.02 (-1.44%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CYTX $1.37 -1.44%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.38
Previous Close $1.39
Daily Range $1.36 - $1.40
52-Week Range $1.26 - $3.93
Market Cap $109.0M
P/E Ratio -2.67
Dividend (Yield) $0.00 (0.0%)
Volume 148,748
Average Daily Volume 475,015
Current FY EPS -$0.26

Sector

Healthcare

Industry

Drugs

Cytori Therapeutics, Inc. (USA) (CYTX) Description

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions. Website: http://www.cytori.com/

News & Commentary Rss Feed

Fast and Furious Health Care Stocks This Week

MannKind, Cytori Therapeutics, and Omeros are among the health care stocks soaring this week.

Stocks Hitting 52-Week Lows

Reasons I Abandoned My Long Position In Cytori

Cytori Therapeutics (CYTX) Q2 2014 Results - Earnings Call Transcript

Ascendiant Downgrades Cytori Therapeutics As ATHENA Trials Are Put On Hold

Stocks Hitting 52-Week Lows

UPDATE: Cytori Says It has Placed Enrollment in Athena On Hold and Puts Athena II Trials On Clinical

UPDATE: Cytori Says It has Placed Enrollment in Athena On Hold and Puts Athena II Trials On Clinical Hold

2 Small Cap Biotechs Insiders And Analysts Are Positive On

Morning Market Movers

Sector Update: Healthcare Shares Flat Pre-Market; Cytori Down 1% on Plans to Sell 4 Mln Units

Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q1 2014 Results - Earnings Call Transcript

See More CYTX News...

CYTX's Top Competitors

CYTX $1.37 (-1.44%)
Current stock: CYTX
AMGN $137.83 (0.41%)
Current stock: AMGN
GILD $107.41 (1.07%)
Current stock: GILD
BIIB $343.36 (0.11%)
Current stock: BIIB